Corrigendum to “Immune checkpoint inhibition in renal cell carcinoma: Mechanisms of resistance and emerging therapeutic strategies” [Biomed. Pharmacother. 193 (2025) 118875] - 10/01/26

Ali Darzi ^a, 1

  Co-first authors.

, Mahla Shokouhfar ^a, 1

  Co-first authors.

, Narges Farajee ^b, 2

  Contributed equally.

, Arezoo Ghafari ^c, 2

  Contributed equally.

, Fatemeh Deldar ^d, Pooya Eini ^e, Ahmad Ghorbani Vanan ^{c, ⁎} , Nastaran Bahrami ^{f, g, ⁎}

^a School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran 

^b School of Medicine, Islamic Azad University of Tehran Medical Sciences, Tehran, Iran 

^c Student Research Committee, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran 

^d Student Research Committee, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran 

^e Cardiovascular Research Center, Rajaie Cardiovascular Institute, Tehran, Iran 

^f Gastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran 

^g Department of Biology, Islamic Azad University, Science and Research Branch, Tehran, Iran 

^⁎Corresponding author.^⁎⁎Corresponding author at: Gastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.Gastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical SciencesTehranIran

Le texte complet de cet article est disponible en PDF.